NCT06397937

Brief Summary

Primary Goal: To test the hypothesis that among stroke patients 18-75 years with ≥3 SDOH risk factors, SHIFT will improve: (1) functional outcomes as measured by the SIS (Primary Outcome), (2) physiological outcomes as measured by changes in blood pressure and cognition, (secondary outcomes) and (3) epigenetic allostatic load biomarkers (exploratory outcome) such as DNA methylation (DNAm) and telomere length, at 6 months and 1-year post-stroke, compared with usual care (UC).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
275

participants targeted

Target at P75+ for not_applicable stroke

Timeline
44mo left

Started Sep 2024

Longer than P75 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress31%
Sep 2024Jan 2030

First Submitted

Initial submission to the registry

April 30, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 3, 2024

Completed
5 months until next milestone

Study Start

First participant enrolled

September 15, 2024

Completed
5.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2030

Last Updated

April 8, 2026

Status Verified

March 1, 2026

Enrollment Period

5.4 years

First QC Date

April 30, 2024

Last Update Submit

April 3, 2026

Conditions

Keywords

strokesocial determinants of healthhealth disparitiescommunity health workershome visits

Outcome Measures

Primary Outcomes (1)

  • Stroke Impact Scale v3.0

    a validated measure of disability and health-related quality of life after stroke

    baseline, 6 months and 1 year

Secondary Outcomes (3)

  • Blood pressure

    baseline, 6 months and 1 year

  • cognition

    baseline, 6 months and 1 year

  • Stroke Specific Quality of Life (SSQOL)

    6 months and 1 year

Other Outcomes (3)

  • Medication Adherence

    6 months and 1 year

  • 30-day readmission rate

    30 days post discharge

  • Epigenetic biomarkers of stress

    baseline, 6 months and 1 year

Study Arms (2)

Intervention

EXPERIMENTAL

The SHIFT intervention team, comprising a community health worker (CHW), community social worker (CSW), and community nurse (CN),will make a first home visit within 72 hours of hospital discharge, and make regular visits to address SDOH barriers identified for each patient, provide individualized counseling, and assist with medication management, risk factor control, and health literacy.

Behavioral: SHIFT team intervention

Usual Care

NO INTERVENTION

All patients will be given standard discharge information, including culturally/racially sensitive stroke education materials for post-stroke care, signs and symptoms of acute stroke, and management of stroke risk factors. Homecare referrals and other rehabilitation services will continue to be provided to discharged patients according to standard-of-care and treating physician referrals. Follow up clinic appointments at 4-6 weeks post discharge will be made with a stroke neurologist per clinical protocol. Thus the only difference between intervention and usual care will be the SHIFT intervention.

Interventions

The SHIFT team, comprising a community health worker (CHW), community social worker (CHW), and community nurse (CN) will visit the participant starting within 72 hours of hospital discharge and provide social service referrals related to food insecurity, housing, immigration, and employment, and assist with medical appointment preparation (CHW), deliver individualized counseling focused on coping skills, reducing caregiver strain, and the psychological distress associated with experiences of racism and SDOH (CSW), and address health literacy and review of treatment goals and medications (CN).

Intervention

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ischemic stroke (arterial subtypes) or primary intracerebral hemorrhage (excluding diagnosis of probable cerebral amyloid angiopathy by Boston Criteria)
  • African American/Black or Hispanic race-ethnicity
  • Age 18-75 years old
  • Have at least 3 SDOH barriers from within the 5 SDOH domains (Social and Community, Education, Economic, neighborhood/environment, Health Care)
  • Have a discharge plan to 1) home with or without home services, or 2) acute rehabilitation with plan to return home after
  • Pre-stroke Modified Rankin Scale score of ≤3
  • Residence in New York City.
  • English or Spanish speaking.
  • Can provide informed consent and engage in the initial assessment prior to stroke discharge
  • Lives in a household with a telephone, and has a caregiver (family member or Home Health Aide) if not fully independent on discharge. If the patient requires a family member to assist with activities of daily living or decision-making, the family member must state a willingness to be present at home visits where their assistance is needed.

You may not qualify if:

  • Discharge disposition to a long-term care facility.
  • Diagnosis of dementia or other neurological diagnosis that affects cognition
  • Diagnosis of active major depression
  • Aphasia severe enough to preclude initial examination
  • Impaired level of consciousness at initial cognitive assessment
  • Subarachnoid hemorrhage
  • Diagnosis of probable cerebral amyloid angiopathy by Boston criteria
  • Life expectancy less than 1 year

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Columbia University Medical Center

New York, New York, 10032, United States

RECRUITING

Related Publications (2)

  • Harris J, Boehme A, Chan L, Moats H, Dugue R, Izeogu C, Pavol MA, Naqvi IA, Williams O, Marshall RS. Allostatic load predicts racial disparities in intracerebral hemorrhage cognitive outcomes. Sci Rep. 2022 Oct 3;12(1):16556. doi: 10.1038/s41598-022-20987-x.

    PMID: 36192526BACKGROUND
  • Mallaiah J, Williams O, Allegrante JP. Development and Validation of a Stroke Literacy Assessment Test for Community Health Workers. Health Educ Behav. 2024 Oct;51(5):764-774. doi: 10.1177/10901981241245050. Epub 2024 Apr 22.

    PMID: 38646736BACKGROUND

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Olajide Williams, MD

    Columbia University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Olajide Williams, MD

CONTACT

Randolph S Marshall, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Phase 3, randomized, blinded outcome
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Neurology

Study Record Dates

First Submitted

April 30, 2024

First Posted

May 3, 2024

Study Start

September 15, 2024

Primary Completion (Estimated)

January 31, 2030

Study Completion (Estimated)

January 31, 2030

Last Updated

April 8, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

To share individual participant data (IPD) of baseline characteristics, follow up, outcomes, etc. based on NIH/NINDS requirements.

Shared Documents
STUDY PROTOCOL
Time Frame
As per NIH/NINDS requirements
Access Criteria
All items required by NIH/NINDS will be publicly shared.

Locations